Close Menu
Home › Successful Use of Immunotherapies in Pediatric Cancer Requires Prioritizing Trial Targets

Successful Use of Immunotherapies in Pediatric Cancer Requires Prioritizing Trial Targets

Sep 25, 2019
|
Christie Rizk
Premium

NEW YORK – Immunotherapeutic drugs have proven to be widely successful in treating a variety of cancers in adults.

Get the full story with
Premium Access

Only $95 for the
first 90 days*

Premium Access gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try Premium Access now.

You may already have institutional access!

Check if I qualify.

Already a Precision Oncology News or 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.
Oct
21
Featured Webinar

Broad Genomic Testing for Oncology Clinical Trials and Clinical Practice

Genomics is a key element in the potential of precision medicine to transform oncology. 

Oct
23
Featured Webinar

Single-Cell Methylation Profiling of Pediatric Tumors via a Unique NGS-based Approach

This webinar will illustrate how single-cell methylation sequencing can be applied to gain significant insight into epigenetic heterogeneity in disease states, advancing cancer research discoveries. 

Oct
24
Featured Webinar

Designing, Decoding & Delivering on Genetic Testing for Inherited Disease at Versiti

This webinar will tell the story of Versiti’s journey in transforming genetic testing from a manual to a digitized process. It will include detail on how the organization succeeded, pain points along the way, a novel approach to variant assessment, and future plans for the program.

Nov
14
Featured Webinar

High-Performance Variant Detection in Somatic Cancer Testing with an Integrated NGS Solution

Sponsored by
Qiagen

This webinar will discuss some of the issues laboratories face when transitioning to next-generation sequencing, and the key features to be considered for a successful implementation in routine testing.

What's Popular?

In Cancer

  1. Colon Cancer Recurrence Clues Identified in Post-Treatment ctDNA Detection

  2. Inivata Collecting Evidence for Liquid Biopsy in Immunotherapy Prediction, Response Monitoring

    Premium

  3. Exact Sciences, Mayo Clinic Launch Real-World Impact Study for Cologuard

  4. Tumor-Derived Organoids ID Colorectal Cancer Patients Who Don't Respond to Irinotecan-Based Chemo

    Premium

  5. Gut Microbiome May Affect Cancer Patients' Responses to Immunotherapy, Emerging Research Shows

    Premium

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.